Keep Pace with the Complexities of Genetic Testing

Although genetic testing accounts for only about 1% to 2% of medical spend, health plans often dedicate a disproportionate amount of time—as much as 15% of clinical reviews and 20% of medical policies—to managing it. Errors and overpayments occur frequently, and waste is common. However, with NIA’s innovative genetic testing solution, powered by Concert Genetics, we conquer the complexities and deliver end-to-end value.

We can help you address the variation and complexity that exists in the genetic testing space while reducing costs through efficiency, transparency and automation. Contact us to learn more.